Sunshine Biopharma SBFM
NASDAQ SBFM
$0.70 -0.07 (-9.01%)
As of: Oct 1, 2026 · 2:04 PM EDT

Sunshine Biopharma (SBFM) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Sunshine Biopharma's Liabilities and Shareholders Equity came in at $33.63 million for Q2 2026, up 5.2% from $31.97 million a year earlier and up 20.4% from the prior quarter.

Analysis

Sunshine Biopharma (SBFM) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Sunshine Biopharma's Liabilities and Shareholders Equity was $30.08 million, down 1.6% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 95.8% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $30.56 million in FY2024 (+11.8%), $27.35 million in FY2023 (-6.5%), $29.24 million in FY2022 and $2.2 million in FY2021 (+110.7%).
  • The Q2 2026 figure represents the highest quarterly Liabilities and Shareholders Equity since Q3 2022.
  • Year-over-year, Liabilities and Shareholders Equity increased in five of the last eight quarters, with growth averaging 3.1%.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q1 2022 (growth of 621.5%), and the weakest in Q2 2023 (a decline of 32.3%).
  • Business Quant data shows SBFM's Liabilities and Shareholders Equity at $27.93 million (Q1 2026), $30.08 million (Q4 2025) and $31.49 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Sunshine Biopharma 1.05 Mn -38.04 Mn 2.43 Mn 33.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.63 Mn
Mar 31, 2026 27.93 Mn
Dec 31, 2025 30.08 Mn
Sep 30, 2025 31.49 Mn
Jun 30, 2025 31.97 Mn
Mar 31, 2025 29.19 Mn
Dec 31, 2024 30.56 Mn
Sep 30, 2024 30.06 Mn
Jun 30, 2024 29.30 Mn
Mar 31, 2024 31.90 Mn
Dec 31, 2023 27.35 Mn
Sep 30, 2023 27.65 Mn
Jun 30, 2023 28.41 Mn
Mar 31, 2023 26.99 Mn
Dec 31, 2022 29.24 Mn
Sep 30, 2022 40.86 Mn
Jun 30, 2022 41.99 Mn
Mar 31, 2022 13.41 Mn
Dec 31, 2021 2.20 Mn
Sep 30, 2021 2.50 Mn
API Access

Sunshine Biopharma Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SBFM&period=max&api_key=YOUR_API_KEY